logo

For the Inventor, By the Inventor

Paris, France

Jean-Louis Moreau

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignee: Institut Pasteur. Active years: 2001-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Louis Moreau. Retrieved from https://idiyas.com/inventor/jean-louis-moreau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 28.6

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 44(Granted Patents)


Company Filing History:

goldMedal7 out of 898 
 
Institut Pasteur
 patents

Years Active: 2001-2010

Loading Chart...
7 patents (USPTO):Explore Patents
1. 7704490 - Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2 (2010-04-27),
2. 7662368 - Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2 (2010-02-16),
3. 7101965 - Peptides of IL-2 (2006-09-05),
4. 6929791 - Peptides of IL-2 and derivatives thereof (2005-08-16),
5. 6825334 - Peptides of IL-2 and derivatives thereof and their use as therapeutic agents (2004-11-30),
6. 6596853 - DNA encoding peptides of IL-2 (2003-07-22),
7. 6168785 - Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents (2001-01-02),

Title: Innovations of Jean-Louis Moreau

Introduction

Jean-Louis Moreau is a prominent inventor based in Paris, France. He has made significant contributions to the field of therapeutic agents, particularly through his work with interleukin-2 (IL-2). With a total of 7 patents to his name, Moreau's innovations have the potential to impact medical treatments significantly.

Latest Patents

Among his latest patents, Moreau has developed a method for inducing selected useful activities of IL-2 in a patient using peptides derived from IL-2. This invention relates to new peptides of IL-2 and their derivatives, which can be utilized as therapeutic agents. Additionally, he has patented a method for inducing SHC phosphorylation, which activates the SHC/MAPK pathway by administering a peptide of IL-2. This also involves new peptides of IL-2 and their derivatives, emphasizing their therapeutic applications.

Career Highlights

Jean-Louis Moreau is affiliated with the prestigious Institut Pasteur, where he conducts his research and development. His work at this renowned institution has allowed him to explore innovative solutions in the medical field, particularly in immunotherapy.

Collaborations

Moreau has collaborated with notable colleagues, including Jacques Theze and Ralph Eckenberg. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Jean-Louis Moreau's contributions to the field of therapeutic agents through his innovative patents highlight his role as a leading inventor in the medical research community. His work continues to pave the way for advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…